{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/fda/warning-letters/check?name=Swisschems","name":"Swisschems","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-08-12T06:57:46.920Z"},"count":1,"matches":[{"id":"4b22bb8bc7060601","posted_date":"2024-12-17","letter_issue_date":"2024-12-10","company_name":"Swisschems","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.ai-analytics.org/fda-warning/4b22bb8bc7060601"}]}